{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-065914","form_type":"8-K","ticker":"LONA","cik":"0001620463","company_name":"LeonaBio, Inc.","filed_at":"2024-05-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.285238+00:00","generated_at":"2026-06-01T07:41:35.930130+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Athira Pharma shareholders approve officer liability limitation charter amendment at 2024 annual meeting","bullets":["Class I directors Kosacz, Litton, and Panzara elected with For votes ranging from 77% to 82% of votes cast (excl. broker non-votes).","Ratification of Ernst & Young as auditor passed: 27,199,785 For, 59,069 Against, 99,855 Abstain.","Amendment to certificate of incorporation limiting officer liability approved: 19,365,835 For, 602,307 Against, 347,812 Abstain.","Broker non-votes were 7,042,755 on director election and charter amendment proposals."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-065914","json":"https://secwatch.observer/filing/0000950170-24-065914.json","markdown":"https://secwatch.observer/filing/0000950170-24-065914.md","text":"https://secwatch.observer/filing/0000950170-24-065914.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1620463/000095017024065914/0000950170-24-065914-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1620463/000095017024065914/atha-20240523.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T07:41:35.930130+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}